ACORDA THERAPEUTICS INC 4
4 · ACORDA THERAPEUTICS INC · Filed Jan 12, 2015
Insider Transaction Report
Form 4
Carrazana Enrique J.
Chief Medical Officer
Transactions
- Sale
Common Stock
2015-01-08$42.01/sh−6,715$282,069→ 33,494 total - Exercise/Conversion
Common Stock
2015-01-09$26.35/sh+18,225$480,229→ 68,522 total - Exercise/Conversion
Common Stock
2015-01-08$30.46/sh+6,715$204,539→ 40,209 total - Exercise/Conversion
Common Stock
2015-01-09$21.52/sh+42,879$922,756→ 111,401 total - Sale
Common Stock
2015-01-09$42.11/sh−77,907$3,280,337→ 33,494 total - Sale
Common Stock
2015-01-12$42.61/sh−8,200$349,400→ 38,665 total - Sale
Common Stock
2015-01-12$43.50/sh−5,171$224,962→ 33,494 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-01-09−16,803→ 23,517 totalExercise: $30.46Exp: 2023-03-06→ Common Stock (16,803 underlying) - Exercise/Conversion
Common Stock
2015-01-09$30.46/sh+16,803$511,819→ 50,297 total - Exercise/Conversion
Common Stock
2015-01-12$21.52/sh+13,371$287,744→ 46,865 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-01-08−6,715→ 40,320 totalExercise: $30.46Exp: 2023-03-06→ Common Stock (6,715 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2015-01-09−18,225→ 6,075 totalExercise: $26.35Exp: 2022-03-15→ Common Stock (18,225 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2015-01-09−42,879→ 32,121 totalExercise: $21.52Exp: 2021-10-15→ Common Stock (42,879 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2015-01-12−13,371→ 18,750 totalExercise: $21.52Exp: 2021-10-15→ Common Stock (13,371 underlying)
Footnotes (8)
- [F1]Exercise and sales pursuant to a 10b5-1 plan.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.00 to $42.13 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.00 to $42.31 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.16 to $43.15 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F5]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $43.23 to $43.80 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F6]The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2013 with the first quarterly installment vested on April 1, 2013.
- [F7]The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2012 with the first quarterly installment vested on April 1, 2012.
- [F8]25% of the shares subject to this option vested on October 15, 2012. The balance of the shares subject to this option vest in equal quarterly installments over the three years thereafter.